Literature DB >> 27074737

Relationship Between Serum High-Sensitivity C-Reactive Protein and Myocardial Infarction in a General Japanese Population.

Teruyuki Sugiyama1, Shizukiyo Ishikawa2, Kazuhiko Kotani1,3, Tadao Gotoh4, Yoshihisa Itoh5, Kazunori Kayaba6, Eiji Kajii1.   

Abstract

BACKGROUND: Due to ethic differences in its serum levels, clinical applicability of high-sensitivity C-reactive protein (hsCRP) to the primary prevention of atherosclerotic events has not completely been established in Japanese people whose hsCRP levels are lower than in Western people. This study investigated the relationship between hsCRP and myocardial infarction (MI) in general Japanese people.
METHODS: In relation to hsCRP, the incidence of MI was determined in a multiregional population-based prospective cohort study (n = 6,637; mean age 54.9 years; 2,513 men/4,124 women).
RESULTS: Fifty-six cases of MI were confirmed during a follow-up period of 10.7 years. The cut-off levels of hsCRP between the highest quartile (fourth quartile) and the other quartiles combined were 0.368 mg/l in men and 0.279 mg/l in women. The hazard ratio (HR) of the highest quartile for MI was significantly greater than that of the other quartiles combined (multivariate-adjusted HR: 2.07, 95% confidence interval: 1.03-4.15) in men, but not in women (1.03, 0.35-2.21).
CONCLUSIONS: In this population, serum hsCRP measurement predicted MI in men, but not in women. Under the low hsCRP level, a method of applicability of hsCRP to a risk assessment for preventing MI among Japanese people should be further explored.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiovascular disease; coronary heart disease; inflammation; population-based cohort study

Mesh:

Substances:

Year:  2016        PMID: 27074737      PMCID: PMC6807251          DOI: 10.1002/jcla.21970

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios.

Authors:  Shizukiyo Ishikawa; Tadao Gotoh; Naoki Nago; Kazunori Kayaba
Journal:  J Epidemiol       Date:  2002-11       Impact factor: 3.211

3.  1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

4.  The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study.

Authors:  Hiroyasu Iso; Hiroyuki Noda; Ai Ikeda; Kazumasa Yamagishi; Manami Inoue; Motoki Iwasaki; Shoichiro Tsugane
Journal:  J Atheroscler Thromb       Date:  2012-07-11       Impact factor: 4.928

Review 5.  Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Curr Pharm Biotechnol       Date:  2012-01       Impact factor: 2.837

Review 6.  C-reactive protein: how conformational changes influence inflammatory properties.

Authors:  Steffen U Eisenhardt; Jan R Thiele; Holger Bannasch; G Bjoern Stark; Karlheinz Peter
Journal:  Cell Cycle       Date:  2009-12-14       Impact factor: 4.534

7.  High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study.

Authors:  Hisatomi Arima; Michiaki Kubo; Koji Yonemoto; Yasufumi Doi; Toshiharu Ninomiya; Yumihiro Tanizaki; Jun Hata; Kiyoshi Matsumura; Mitsuo Iida; Yutaka Kiyohara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-10       Impact factor: 8.311

Review 8.  Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke.

Authors:  Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2007-12-17       Impact factor: 4.928

9.  C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study.

Authors:  Hiroyasu Iso; Renzhe Cui; Chigusa Date; Shogo Kikuchi; Akiko Tamakoshi
Journal:  Atherosclerosis       Date:  2009-04-24       Impact factor: 5.162

Review 10.  Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies.

Authors:  Aydin Nazmi; Cesar G Victora
Journal:  BMC Public Health       Date:  2007-08-17       Impact factor: 3.295

View more
  3 in total

Review 1.  Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies.

Authors:  Xingjin Yang; Dongdong Zhang; Yang Zhao; Dechen Liu; Quanman Li; Chunmei Guo; Gang Tian; Minghui Han; Ranran Qie; Shengbing Huang; Qionggui Zhou; Yang Zhao; Yifei Feng; Xiaoyan Wu; Yanyan Zhang; Yang Li; Yuying Wu; Cheng Cheng; Dongsheng Hu; Liang Sun
Journal:  J Hum Hypertens       Date:  2021-05-12       Impact factor: 3.012

2.  Association of high sensitive C-reactive protein with coronary heart disease: a Mendelian randomization study.

Authors:  Qian Zhuang; Chong Shen; Yanchun Chen; Xianghai Zhao; Pengfei Wei; Junxiang Sun; Yanni Ji; Xiaotian Chen; Song Yang
Journal:  BMC Med Genet       Date:  2019-11-06       Impact factor: 2.103

3.  Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD.

Authors:  Changhyun Lee; Keun Hyung Park; Young Su Joo; Ki Heon Nam; Tae-Ik Chang; Ea Wha Kang; Joongyub Lee; Yun Kyu Oh; Ji Yong Jung; Curie Ahn; Kyu-Beck Lee; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Seung Hyeok Han
Journal:  J Am Heart Assoc       Date:  2020-10-23       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.